PRISM BioLab Co.,LTD (TYO:206A)
Japan · Delayed Price · Currency is JPY 141.00
0.00 (0.00%)
Oct 6, 2026, 3:30 PM JST
PRISM BioLab Co.,LTD Market Cap
PRISM BioLab Co.,LTD has a market cap or net worth of 5.21 billion as of October 6, 2026. Its market cap has decreased by -15.40% in one year.
Market Cap
5.21B
Enterprise Value
2.88B
Revenue
737.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
141.00
ChartMarket Cap Chart
Since July 2, 2024, PRISM BioLab Co.,LTD's market cap has decreased from 17.84B to 5.21B, a decrease of -70.79%. That is a compound annual growth rate of -41.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 5.21B | -9.50% |
| Dec 30, 2025 | 5.76B | -44.77% |
| Dec 30, 2024 | 10.43B | -41.56% |
| Jul 2, 2024 | 17.84B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MEDINET | 6.81B |
| BrightPath Biotherapeutics | 6.81B |
| Cyfuse Biomedical K.K. | 6.53B |
| CellSource | 6.23B |
| TMS Co., Ltd. | 5.75B |
| Soiken Holdings | 5.62B |
| Noile-Immune Biotech | 5.08B |
| Chordia Therapeutics | 4.79B |